Article
Roller Compaction: New Trends, Challenges and Solutions
This article discusses why roller compaction is a robust option when developing a tablet or capsule formulation.
View Now
Article
Strategies for De-risking Early-Phase Oral Small Molecule Drug Development
Summary: Characterize lead molecules and develop the best pathway to bring them to Phase I studies and beyond.
View Now
Article
Partnering for Success: Strategies to Mitigate Common Pitfalls in Early Drug Development
Summary: Thousands of drug candidates are abandoned annually due to solubility and bioavailability issues, but advanced formulation technologies can profoundly impact how a drug compound...
View Now
Webinars
Early Drug Development: Strategy and Solution
This webinar focuses on the key considerations for transitioning small molecules from preclinical through clinical development.
View Now
Webinars
From Development to Commercialization: Overcoming Scale-Up Issues
Summary: Recorded at Manufacturing Chemist Live 2020, this presentation discusses some of the key issues to consider when planning for the scale-up of a small molecule development program.
View Now
Article
Analyzing Product Formulation Using Raman Spectroscopy
Comparing the dissolution rates and pellet structure of branded Sporanox® with three similar generic products, raman spectroscopy revealed recrystallizing API slowed the dissolution rate.
View Now
Article
NMR and Mass Spectrometry in Pharmaceutical Development
Nuclear Magnetic Resonance spectroscopy and Mass Spectrometry are powerful techniques for the characterization and quantification of compounds.
View Now
Article
Principles of Raman Spectroscopy and Application to Pharmaceutical Development
Raman Spectroscopy is used for applications like polymorph identification, analysis of API form, & evaluation of component distribution within a formulation.
View Now
Webinars
Discover the Latest Funding, Drug Development and Clinical Solutions Strategies
Summary: Dramatically shifting the attention of the industry, Covid-19 forced orphan developers to re-examine their go-to-market strategies.
View Now
Webinars
Derisking Orphan Drug Programs in 2020 and Beyond
Summary: Dramatically shifting the attention of the industry, Covid-19 forced orphan developers to re-examine their go-to-market strategies.
View Now
